







Yeast Systematic Name | Yeast Symbol | SGDID | Analog Name | Analog Description | EC | Organism | Disease | Structure | Uniprot | Human ID | Human Symbol | HHsearch Probability | HHsearch E_value | HHsearch P_value | HHsearch Score | Flag Disease related | Flag Homo sapiens | Flag Mus musculus | Flag Danio rerio | Flag Drosophila melanogaster | Flag Caenorhabditis elegans | Flag Arabidopsis thaliana | Flag Escherichia coli |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
YAL021C | CCR4 | SGDID:S000000019 | AF_0580 |
AF_0580 |
Archaeoglobus fulgidus | 2voa_a | O29675 | 98.20 | 3.40E-10 | 5.00E-14 | 95.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YAL021C | CCR4 | SGDID:S000000019 | Tdp2 Ttrap |
Tyrosyl-DNA phosphodiesterase 2 (Tyr-DNA phosphodiesterase 2) (EC 3.1.4.-) (5'-tyrosyl-DNA phosphodiesterase) (5'-Tyr-DNA phosphodiesterase) (TRAF and TNF receptor-associated protein) |
3.1.4.- | Mus musculus | 5ht2_b | Q9JJX7 | 98.10 | 5.10E-10 | 7.60E-14 | 94.80 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
YAL021C | CCR4 | SGDID:S000000019 | cdtB |
Cytolethal distending toxin protein B |
Haemophilus ducreyi | 1sr4_b | O06523 | 98.40 | 7.70E-11 | 1.10E-14 | 104.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YAL021C | CCR4 | SGDID:S000000019 | INPP5B OCRL2 |
Type II inositol 1,4,5-trisphosphate 5-phosphatase (EC 3.1.3.36) (75 kDa inositol polyphosphate-5-phosphatase) (Phosphoinositide 5-phosphatase) (5PTase) |
3.1.3.36 | Homo sapiens | X-Linked Recessive Disease,Amyotrophic Lateral Sclerosis 11,Yunis-Varon Syndrome,Amyotrophic Lateral Sclerosis 1,Charcot-Marie-Tooth Disease, Type 4b3,Fanconi Syndrome,Dent Disease 1,Dent Disease 2,Charcot-Marie-Tooth Disease, Type 4j,Frontotemporal Dementia And/Or Amyotrophic Lateral Sclerosis 3,Lowe Oculocerebrorenal Syndrome,Charcot-Marie-Tooth Disease, Axonal, Type 2e,Joubert Syndrome 1 |
4cml_a | P32019 | ENSG00000204084 | INPP5B | 98.10 | 6.00E-10 | 7.60E-14 | 104.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YAL021C | CCR4 | SGDID:S000000019 | INPPL1 SHIP2 |
Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1) (INPPL-1) (Protein 51C) (SH2 domain-containing inositol 5'-phosphatase 2) (SH2 domain-containing inositol phosphatase 2) (SHIP-2) |
3.1.3.86 | Homo sapiens | Diabetes Mellitus,Schneckenbecken Dysplasia,Breast Cancer,Body Mass Index Quantitative Trait Locus 11,Type 2 Diabetes Mellitus,Cone-Rod Dystrophy 19,Lowe Oculocerebrorenal Syndrome,Opsismodysplasia |
5okm_b | O15357 | ENSG00000165458 | INPPL1 | 98.10 | 9.90E-10 | 1.20E-13 | 110.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YAL021C | CCR4 | SGDID:S000000019 | INPP5D SHIP SHIP1 |
Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 (EC 3.1.3.86) (Inositol polyphosphate-5-phosphatase D) (EC 3.1.3.56) (Inositol polyphosphate-5-phosphatase of 145 kDa) (SIP-145) (Phosphatidylinositol 4,5-bisphosphate 5-phosphatase) (EC 3.1.3.36) (SH2 domain-containing inositol 5'-phosphatase 1) (SH2 domain-containing inositol phosphatase 1) (SHIP-1) (p150Ship) (hp51CN) |
3.1.3.36,3.1.3.56,3.1.3.86 | Homo sapiens | Leukemia, Chronic Myeloid,Leukemia, Acute Lymphoblastic,Crohn'S Disease,Inflammatory Bowel Disease,Severe Congenital Neutropenia,Juvenile Myelomonocytic Leukemia,Lymphoproliferative Syndrome |
6ibd_a | Q92835 | ENSG00000168918 | INPP5D | 98.20 | 4.10E-10 | 4.60E-14 | 115.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YAL021C | CCR4 | SGDID:S000000019 | APEX1 APE APE1 APEX APX HAP1 REF1 |
DNA-(apurinic or apyrimidinic site) endonuclease (EC 3.1.-.-) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) endonuclease, mitochondrial] |
3.1.-.- | Homo sapiens | Cheilitis,Amyotrophic Lateral Sclerosis 1,Senile Cataract,Differentiated Thyroid Carcinoma,Pediatric T-Cell Leukemia,Spinocerebellar Ataxia Type 1 With Axonal Neuropathy,Acoustic Neuroma,Cystic Fibrosis,Actinobacillosis,Pediatric Ependymoma,Cockayne Syndrome,Actinic Cheilitis,Colorectal Cancer,Attenuated Familial Adenomatous Polyposis,Xeroderma Pigmentosum, Complementation Group D,Xeroderma Pigmentosum, Variant Type,Fanconi Anemia, Complementation Group A,Xeroderma Pigmentosum, Complementation Group G,Respiratory Failure,Cockayne Syndrome B,Ataxia, Early-Onset, With Oculomotor Apraxia And Hypoalbuminemia,Lung Cancer |
5dff_a | P27695 | ENSG00000100823 | APEX1 | 98.10 | 8.40E-10 | 1.20E-13 | 94.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YAL021C | CCR4 | SGDID:S000000019 | NOCT CCR4 CCRN4L NOC |
Nocturnin (EC 3.1.3.-) (Carbon catabolite repression 4-like protein) |
3.1.3.- | Homo sapiens | 6bt1_a | Q9UK39 | ENSG00000151014 | NOCT | 99.20 | 6.30E-16 | 9.00E-20 | 139.00 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YAL021C | CCR4 | SGDID:S000000019 | Lebu_1528 |
Lebu_1528 |
Leptotrichia buccalis | 3teb_b | C7NB70 | 98.30 | 9.10E-11 | 1.40E-14 | 99.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YAL021C | CCR4 | SGDID:S000000019 | BT_3783 |
BT_3783 |
Bacteroides thetaiotaomicron | 3mpr_a | Q8A183 | 98.40 | 4.20E-11 | 6.00E-15 | 106.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YAL021C | CCR4 | SGDID:S000000019 | DNASE1 DNL1 |
Deoxyribonuclease-1 (EC 3.1.21.1) (Deoxyribonuclease I) (DNase I) |
3.1.21.1 | Bos taurus | 3w3d_b | P00639 | 98.30 | 1.00E-10 | 1.40E-14 | 101.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YAL021C | CCR4 | SGDID:S000000019 | SMPD3 |
Sphingomyelin phosphodiesterase 3 (EC 3.1.4.12) (Neutral sphingomyelinase 2) (nSMase-2) (nSMase2) (Neutral sphingomyelinase II) |
3.1.4.12 | Homo sapiens | Dentinogenesis Imperfecta,Aggressive Systemic Mastocytosis,Farber Lipogranulomatosis,Brittle Bone Disorder,Coffin-Siris Syndrome 1,Pituitary Hormone Deficiency, Combined, 2 |
5uvg_a | Q9NY59 | 98.80 | 4.20E-13 | 5.10E-17 | 131.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||
YAL021C | CCR4 | SGDID:S000000019 | Beta-hemolysin |
Beta-hemolysin |
Staphylococcus aureus | 3i41_a | A7LAI8 | 98.40 | 4.60E-11 | 6.40E-15 | 108.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YAL021C | CCR4 | SGDID:S000000019 | PDE12 |
2',5'-phosphodiesterase 12 (2'-PDE) (2-PDE) (EC 3.1.4.-) (Mitochondrial deadenylase) (EC 3.1.13.4) |
3.1.13.4 | Homo sapiens | Rasopathy,Noonan Syndrome 1,Noonan Syndrome 2,Microphthalmia With Limb Anomalies |
4z0v_a | Q6L8Q7 | ENSG00000174840 | PDE12 | 99.90 | 3.10E-31 | 3.70E-35 | 269.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YAL021C | CCR4 | SGDID:S000000019 | syj1 SPBC2G2.02 |
Inositol-1,4,5-trisphosphate 5-phosphatase 1 (EC 3.1.3.36) (Synaptojanin-like protein 1) |
3.1.3.36 | Schizosaccharomyces pombe | 1i9z_a | O43001 | 98.10 | 7.70E-10 | 9.70E-14 | 105.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YAL021C | CCR4 | SGDID:S000000019 | xthA NMB0399 |
xthA NMB0399 |
3.1.11.2 | Neisseria meningitidis | 2jc4_a | Q9K100 | 98.00 | 1.70E-09 | 2.60E-13 | 90.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YAL021C | CCR4 | SGDID:S000000019 | BVU_0621 |
BVU_0621 |
Bacteroides vulgatus | 3g6s_a | A6KY15 | 98.50 | 1.10E-11 | 1.60E-15 | 107.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YAL021C | CCR4 | SGDID:S000000019 | OCRL OCRL1 |
Inositol polyphosphate 5-phosphatase OCRL (EC 3.1.3.36) (EC 3.1.3.56) (Inositol polyphosphate 5-phosphatase OCRL-1) (OCRL-1) (Lowe oculocerebrorenal syndrome protein) (Phosphatidylinositol 3,4,5-triphosphate 5-phosphatase) (EC 3.1.3.86) |
3.1.3.36,3.1.3.56,3.1.3.86 | Homo sapiens | Cataract-Glaucoma,X-Linked Recessive Disease,Renal Tubular Transport Disease,Legionnaire Disease,Nephrocalcinosis,Cataract,Cystinuria,Donnai-Barrow Syndrome,Rickets,Fanconi Syndrome,Aminoaciduria,Chromosome 14q11-Q22 Deletion Syndrome,Renal Tubular Acidosis,Lens Disease,Dent Disease 1,Hydrophthalmos,Disease Of Mental Health,Glaucoma 3, Primary Congenital, A,Hypophosphatemic Rickets, X-Linked Recessive,Dent Disease 2,Aniseikonia,Hypophosphatemia,X-Linked Monogenic Disease,Lowe Oculocerebrorenal Syndrome |
4cmn_a | Q01968 | ENSG00000122126 | OCRL | 98.50 | 2.70E-11 | 3.30E-15 | 118.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YAL021C | CCR4 | SGDID:S000000019 | LmAP LMJF_16_0680 |
LmAP LMJF_16_0680 |
3.1.-.- | Leishmania major | 2j63_a | O15922 | 98.80 | 1.10E-12 | 1.30E-16 | 134.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YAL021C | CCR4 | SGDID:S000000019 | CNOT6L CCR4B |
CCR4-NOT transcription complex subunit 6-like (EC 3.1.13.4) (Carbon catabolite repressor protein 4 homolog B) |
3.1.13.4 | Homo sapiens | 5dv4_a | Q96LI5 | ENSG00000138767 | CNOT6L | 99.80 | 5.50E-24 | 6.50E-28 | 214.30 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YAL021C | CCR4 | SGDID:S000000019 | CCR4 YAL021C FUN27 |
CCR4-Not complex 3'-5'-exoribonuclease subunit Ccr4 (EC 3.1.13.4) (Carbon catabolite repressor protein 4) (Cytoplasmic deadenylase) (Glucose-repressible alcohol dehydrogenase transcriptional effector) |
3.1.13.4 | Saccharomyces cerevisiae | 4b8c_d | P31384 | 100.00 | 6.00E-197 | 6.00E-201 | 1647.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YAL021C | CCR4 | SGDID:S000000019 | Y63D3A.4 |
5'-tyrosyl-DNA phosphodiesterase (5'-Tyr-DNA phosphodiesterase) (EC 3.1.4.-) |
3.1.4.- | Caenorhabditis elegans | 4fva_a | Q9XWG3 | 98.40 | 3.80E-11 | 5.50E-15 | 102.80 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | |||
YAL021C | CCR4 | SGDID:S000000019 | LORF2 |
LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)] |
2.7.7.49 | Homo sapiens | 1vyb_a | O00370 | 98.10 | 8.40E-10 | 1.30E-13 | 92.00 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YAL021C | CCR4 | SGDID:S000000019 | cdtB STY1886 t1111 |
Cytolethal distending toxin subunit B homolog (CDT B) (Deoxyribonuclease CdtB) (EC 3.1.-.-) |
3.1.-.- | Salmonella typhi | 4k6l_f | Q8Z6A7 | 98.00 | 1.90E-09 | 2.60E-13 | 95.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YAL021C | CCR4 | SGDID:S000000019 | sph |
Sphingomyelinase C (SMase) (EC 3.1.4.12) (Cereolysin B) (SMPLC) (Sphingomyelin phosphodiesterase) |
3.1.4.12 | Bacillus cereus | 2ddr_a | P11889 | 98.80 | 3.60E-13 | 5.20E-17 | 119.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YAL021C | CCR4 | SGDID:S000000019 | smcL |
Sphingomyelinase C (SMase) (EC 3.1.4.12) (Sphingomyelin phosphodiesterase) |
3.1.4.12 | Listeria ivanovii | 1zwx_a | Q9RLV9 | 98.50 | 1.10E-11 | 1.60E-15 | 109.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YAL021C | CCR4 | SGDID:S000000019 | Bcav_3678 |
Bcav_3678 |
Beutenbergia cavernae | 4ruw_a | C5C3L1 | 98.40 | 4.10E-11 | 5.00E-15 | 119.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YAL021C | CCR4 | SGDID:S000000019 | EF_1237 |
EF_1237 |
Enterococcus faecalis | 3l1w_d | Q835Y1 | 98.60 | 4.40E-12 | 6.60E-16 | 107.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YAL021C | CCR4 | SGDID:S000000019 | NP |
Nitrophorin Cim l NP (NP) (Salivary nitrophorin) (cNP) (allergen Cim l NP) |
Cimex lectularius | 4l1y_a | O76745 | 98.30 | 1.70E-10 | 2.40E-14 | 102.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YAL021C | CCR4 | SGDID:S000000019 | INPP5E |
Phosphatidylinositol polyphosphate 5-phosphatase type IV (72 kDa inositol polyphosphate 5-phosphatase) (Inositol polyphosphate-5-phosphatase E) (Phosphatidylinositol 4,5-bisphosphate 5-phosphatase) (EC 3.1.3.36) (Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase) (EC 3.1.3.86) |
3.1.3.36,3.1.3.86, | Homo sapiens | Polycystic Kidney Disease,Coach Syndrome 1,Bardet-Biedl Syndrome,Clubfoot,Cohen Syndrome,Renal Dysplasia, Cystic,Familial Clubfoot With Or Without Associated Lower Limb Anomalies,Joubert Syndrome 3,Retinal Ciliopathy,Nephronophthisis,Leber Plus Disease,Posterior Pituitary Gland Neoplasm,Fundus Dystrophy,Interstitial Lung Disease,Spinocerebellar Ataxia 29,Parkinson Disease 20, Early-Onset,Respiratory Failure,Cleft Palate, Isolated,Dent Disease 1,Clubfoot, Congenital, With Or Without Deficiency Of Long Bones And/Or Mirror-Image Polydactyly,Mental Retardation, Truncal Obesity, Retinal Dystrophy, And Micropenis Syndrome,Polydactyly,Macrocephaly/Autism Syndrome,Odontochondrodysplasia,Patent Ductus Arteriosus 1,Lowe Oculocerebrorenal Syndrome,Behr Syndrome,Joubert Syndrome 1 |
2xsw_a | Q9NRR6 | ENSG00000148384 | INPP5E | 98.90 | 2.70E-13 | 3.10E-17 | 134.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YAL021C | CCR4 | SGDID:S000000019 | smc |
smc |
3.1.4.12 | Streptomyces griseocarneus | 3wcx_a | A6P7M9 | 98.70 | 2.00E-12 | 2.90E-16 | 114.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YAL021C | CCR4 | SGDID:S000000019 | tdp2 ttrap ttrapl si:ch211-81e5.5 si:dkey-218n20.5 |
Tyrosyl-DNA phosphodiesterase 2 (Tyr-DNA phosphodiesterase 2) (EC 3.1.4.-) (5'-tyrosyl-DNA phosphodiesterase) (5'-Tyr-DNA phosphodiesterase) (TRAF and TNF receptor-associated protein homolog) |
3.1.4.- | Danio rerio | 6ca4_a | Q5XJA0 | 98.10 | 5.60E-10 | 8.20E-14 | 94.20 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |